CureVac N.V.

NASDAQ:CVAC   3:59:53 PM EDT
7.51
-0.04 (-0.53%)
Other Pre-Announcement

Curevac Starts Phase 1 Clinical Study Of Modified, Omicron-Targeting Covid-19 Vaccine Candidate

Published: 08/18/2022 11:25 GMT
CureVac N.V. (CVAC) - Curevac Starts Phase 1 Clinical Study of Modified, Omicron-targeting Covid-19 Vaccine Candidate.